Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2003 | 12-2002 | 06-2002 | 12-2001 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 0 | N/A | 1,264 |
| Inventories | 17,296 | 21,009 | 19,302 | 20,424 |
| Other current assets | 27,631 | 26,674 | 25,450 | 22,728 |
| TOTAL | $45,297 | $47,683 | $45,124 | $44,416 |
| Non-Current Assets | ||||
| PPE Net | 5,572 | 6,180 | 6,324 | 5,318 |
| Intangibles | 5,730 | 5,175 | 5,284 | 0 |
| TOTAL | $11,302 | $11,355 | $11,608 | $5,318 |
| Total Assets | $56,599 | $59,038 | $56,732 | $49,734 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 8,280 | 12,650 | 6,261 | 3,000 |
| Accounts payable and accrued liabilities | 29,224 | N/A | 31,709 | N/A |
| Other current liabilities | N/A | 33,141 | N/A | 36,547 |
| TOTAL | $42,420 | $45,791 | $42,445 | $39,547 |
| Non-Current Liabilities | ||||
| Long Term Debt | 6,708 | N/A | 8,467 | N/A |
| Other Non-Current Liabilities | 0 | 6,475 | 71 | 7,433 |
| TOTAL | $6,708 | $6,475 | $8,538 | $7,433 |
| Total Liabilities | $49,128 | $52,266 | $50,983 | $46,980 |
| Shareholders' Equity | ||||
| Common Shares | 510 | 504 | 504 | 498 |
| Retained earnings | -21,542 | -22,240 | -23,282 | -24,527 |
| Other shareholders' equity | 1,720 | 1,725 | 1,744 | 0 |
| TOTAL | $7,471 | $6,772 | $5,749 | $2,754 |
| Total Liabilities And Equity | $56,599 | $59,038 | $56,732 | $49,734 |